ACC AHA guidelines classification scheme: Difference between revisions
Jump to navigation
Jump to search
m Robot: Changing Category:Up to date to Category:Up-To-Date |
|||
Line 34: | Line 34: | ||
{{SIB}} | {{SIB}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Up | [[Category:Up-To-Date]] | ||
[[Category:Up to date cardiology]] | [[Category:Up to date cardiology]] | ||
Revision as of 20:29, 30 September 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The Class designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation.
Classification of Recommendations
- Class I: Benefit >>> Risk
- Conditions for which there is evidence and/or general agreement that a given procedure or treatment is beneficial, useful, and effective.
- Class II: Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.
- Class IIa: Benefit >> Risk
- Weight of evidence/opinion is in favor of usefulness/efficacy.
- Class IIb: Benefit ≥ Risk
- Usefulness/efficacy is less well established by evidence/opinion.
- Class III: Risk ≥ Benefit
- Conditions for which there is evidence and/or general agreement that a procedure/treatment is not useful/effective and in some cases may be harmful.
Use the Level of Evidence designation to indicate the strength of the data associated with that recommendation.
Level of Evidence
- Level of Evidence A: Data derived from multiple randomized clinical trials or meta-analyses.
- Level of Evidence B: Data derived from a single randomized trial, or nonrandomized studies.
- Level of Evidence C: Only consensus opinion of experts,case studies, or standard-of-care.
Applying Classification of Recommendations and Level of Evidence
“ | ” |